Results 181 to 190 of about 42,337 (292)

Nesidioblastosis, myelodysplastic syndrome and nodular diabetic glomerulosclerosis in an elderlynondiabetic woman: an autopsy report [PDF]

open access: bronze, 1999
Shih-Peng Yeh   +5 more
openalex   +1 more source

Understanding supply sustainability of plasma‐derived medicinal products: Drivers and consequences of shortages

open access: yesVox Sanguinis, EarlyView.
Abstract Plasma‐derived medicinal products (PDMPs), particularly immunoglobulins (Igs), are essential treatments for numerous diseases, often serving as the primary therapeutic option and playing a critical role in patient care. The human origin of these products, however, can lead to supply constraints due to a lack of plasma collection, market ...
Miriam Belmonte   +4 more
wiley   +1 more source

Splicing of erythroid transcription factor is associated with therapeutic response in myelodysplastic syndromes. [PDF]

open access: yesJ Clin Invest
Aluri S   +28 more
europepmc   +1 more source

A case of familial colorectal adenoid tumor complicating myelodysplastic syndrome.

open access: bronze, 1994
但馬 史人   +7 more
openalex   +2 more sources

Histologically verified penile lichen sclerosus—Incidence in Denmark over 26 years and long‐term risk of penile and non‐penile cancer

open access: yesInternational Journal of Cancer, Volume 157, Issue 6, Page 1086-1093, 15 September 2025.
What's new? About half of penile squamous cell carcinomas are causally associated with inflammatory conditions such as lichen sclerosus (LSc), but few large‐scale studies have assessed the risk of penile cancer in men with LSc. Here, the authors conducted a large nationwide study in Denmark to estimate the risk of penile and non‐penile cancer in men ...
Marianne Gardar Stærk   +5 more
wiley   +1 more source

Transforming Growth Factor‐Beta Signaling in Cancer: Therapeutic Implications, Challenges, and Pathways to Progress

open access: yesMedComm – Oncology, Volume 4, Issue 3, September 2025.
TGF‐β inhibition is emerging as a promising cancer therapy, yet translating laboratory success to bedside implementation has suffered significant setbacks. The associated challenges include adverse drug reactions, inadequate predictive models, and activation of alternative signaling pathways.
Faizah A. Alabi   +5 more
wiley   +1 more source

A correlation of ineffective erythropoiesis and dysregulated signaling pathways in myelodysplastic syndromes/neoplasms. [PDF]

open access: yesExp Hematol Oncol
Wu J   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy